PNB Gilts Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 29, 2025, 11:21 am

Competitors of PNB Gilts Ltd

All Competitor Stocks of PNB Gilts Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:08 am

Below is a detailed analysis of the quarterly data for PNB Gilts Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 419.00 Cr.. The value appears strong and on an upward trend. It has increased from 362.00 Cr. (Dec 2024) to 419.00 Cr., marking an increase of 57.00 Cr..
• For Expenses, as of Mar 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 59.00 Cr. (Dec 2024) to 12.00 Cr., marking a decrease of 47.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 407.00 Cr.. The value appears strong and on an upward trend. It has increased from 303.00 Cr. (Dec 2024) to 407.00 Cr., marking an increase of 104.00 Cr..
• For OPM %, as of Mar 2025, the value is 97.00%. The value appears strong and on an upward trend. It has increased from 84.00% (Dec 2024) to 97.00%, marking an increase of 13.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 307.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 315.00 Cr. (Dec 2024) to 307.00 Cr., marking a decrease of 8.00 Cr..
• For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from -12.00 Cr. (Dec 2024) to 99.00 Cr., marking an increase of 111.00 Cr..
• For Tax %, as of Mar 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from -13.00% (Dec 2024) to 24.00%, marking an increase of 37.00%.
• For Net Profit, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from -10.00 Cr. (Dec 2024) to 75.00 Cr., marking an increase of 85.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.17. The value appears strong and on an upward trend. It has increased from -0.56 (Dec 2024) to 4.17, marking an increase of 4.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 1:35 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:56 pm

Below is a detailed analysis of the balance sheet data for PNB Gilts Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 180.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 180.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,365.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,150.00 Cr. (Mar 2024) to 1,365.00 Cr., marking an increase of 215.00 Cr..
• For Borrowings, as of Mar 2025, the value is 22,384.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 22,403.00 Cr. (Mar 2024) to 22,384.00 Cr., marking a decrease of 19.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 773.00 Cr.. The value appears to be improving (decreasing). It has decreased from 807.00 Cr. (Mar 2024) to 773.00 Cr., marking a decrease of 34.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 24,703.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24,540.00 Cr. (Mar 2024) to 24,703.00 Cr., marking an increase of 163.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 23,165.00 Cr.. The value appears strong and on an upward trend. It has increased from 23,008.00 Cr. (Mar 2024) to 23,165.00 Cr., marking an increase of 157.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,532.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,525.00 Cr. (Mar 2024) to 1,532.00 Cr., marking an increase of 7.00 Cr..
• For Total Assets, as of Mar 2025, the value is 24,703.00 Cr.. The value appears strong and on an upward trend. It has increased from 24,540.00 Cr. (Mar 2024) to 24,703.00 Cr., marking an increase of 163.00 Cr..

However, the Borrowings (22,384.00 Cr.) are higher than the Reserves (₹1,365.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for PNB Gilts Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 12.95. This value is within the healthy range. It has increased from 3.86 (Mar 24) to 12.95, marking an increase of 9.09.
• For Diluted EPS (Rs.), as of Mar 25, the value is 12.95. This value is within the healthy range. It has increased from 3.86 (Mar 24) to 12.95, marking an increase of 9.09.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.14. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 13.14, marking an increase of 8.43.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 85.84. It has increased from 73.87 (Mar 24) to 85.84, marking an increase of 11.97.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 85.84. It has increased from 73.87 (Mar 24) to 85.84, marking an increase of 11.97.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 93.10. It has increased from 87.57 (Mar 24) to 93.10, marking an increase of 5.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 90.25. This value is within the healthy range. It has increased from 84.54 (Mar 24) to 90.25, marking an increase of 5.71.
• For PBIT / Share (Rs.), as of Mar 25, the value is 90.06. This value is within the healthy range. It has increased from 83.69 (Mar 24) to 90.06, marking an increase of 6.37.
• For PBT / Share (Rs.), as of Mar 25, the value is 17.27. This value is within the healthy range. It has increased from 5.49 (Mar 24) to 17.27, marking an increase of 11.78.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.95. This value is within the healthy range. It has increased from 3.86 (Mar 24) to 12.95, marking an increase of 9.09.
• For PBDIT Margin (%), as of Mar 25, the value is 96.93. This value is within the healthy range. It has increased from 96.54 (Mar 24) to 96.93, marking an increase of 0.39.
• For PBIT Margin (%), as of Mar 25, the value is 96.72. This value exceeds the healthy maximum of 20. It has increased from 95.56 (Mar 24) to 96.72, marking an increase of 1.16.
• For PBT Margin (%), as of Mar 25, the value is 18.55. This value is within the healthy range. It has increased from 6.26 (Mar 24) to 18.55, marking an increase of 12.29.
• For Net Profit Margin (%), as of Mar 25, the value is 13.90. This value exceeds the healthy maximum of 10. It has increased from 4.40 (Mar 24) to 13.90, marking an increase of 9.50.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.08. This value is within the healthy range. It has increased from 5.21 (Mar 24) to 15.08, marking an increase of 9.87.
• For Return on Capital Employeed (%), as of Mar 25, the value is 104.64. This value is within the healthy range. It has decreased from 112.50 (Mar 24) to 104.64, marking a decrease of 7.86.
• For Return On Assets (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 5. It has increased from 0.28 (Mar 24) to 0.94, marking an increase of 0.66.
• For Total Debt / Equity (X), as of Mar 25, the value is 14.48. This value exceeds the healthy maximum of 1. It has decreased from 16.84 (Mar 24) to 14.48, marking a decrease of 2.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.06. There is no change compared to the previous period (Mar 24) which recorded 0.06.
• For Current Ratio (X), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 1.5. It has increased from 1.06 (Mar 24) to 1.07, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 1.07, marking an increase of 0.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 3. It has increased from 1.08 (Mar 24) to 1.24, marking an increase of 0.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 3. It has increased from 1.05 (Mar 24) to 1.18, marking an increase of 0.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 23,567.20. It has decreased from 24,070.34 (Mar 24) to 23,567.20, marking a decrease of 503.14.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 14.06. This value exceeds the healthy maximum of 3. It has decreased from 15.27 (Mar 24) to 14.06, marking a decrease of 1.21.
• For EV / EBITDA (X), as of Mar 25, the value is 14.51. This value is within the healthy range. It has decreased from 15.82 (Mar 24) to 14.51, marking a decrease of 1.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.25 (Mar 24) to 0.86, marking a decrease of 0.39.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 1. It has decreased from 1.48 (Mar 24) to 0.93, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.25 (Mar 24) to 0.86, marking a decrease of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.16. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.16, marking an increase of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness